skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sphingosine kinase-1 mediates androgen-induced osteoblast cell growth

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [2];  [1];  [1]
  1. CNRS, Institut de Pharmacologie et de Biologie Structurale, Toulouse F-31000 (France)
  2. CHU Toulouse, Hopital Rangueil, Service d'orthopedie et Traumatologie, Toulouse F-31000 (France)

Herein we report that the lipid kinase sphingosine kinase-1 (SphK1) is instrumental in mediating androgen-induced cell proliferation in osteoblasts. Dihydrotestosterone (DHT) triggered cell growth in steroid-deprived MC3T3 cells, which was associated with a rapid stimulation of SphK1 and activation of both Akt and ERK signaling pathways. This mechanism relied on functional androgen receptor/PI3K/Akt nongenotropic signaling as pharmacological antagonists could block SphK1 stimulation by DHT and its consequences. Finally, SphK1 inhibition not only abrogated DHT-induced ERK activation but also blocked cell proliferation, while ERK inhibition had no impact, suggesting that SphK1 was critical for DHT signaling yet independently of the ERK.

OSTI ID:
22199981
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 391, Issue 1; Other Information: Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Ghrelin inhibits the apoptosis of MC3T3-E1 cells through ERK and AKT signaling pathway
Journal Article · Fri Nov 01 00:00:00 EDT 2013 · Toxicology and Applied Pharmacology · OSTI ID:22199981

Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells
Journal Article · Fri Apr 15 00:00:00 EDT 2016 · Biochemical and Biophysical Research Communications · OSTI ID:22199981

Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling
Journal Article · Sat Jun 10 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22199981